As a leader in the global clinical research (CRO) industry, Ergomed offers a full-service suite of services specifically designed and tested to match the needs of the most demanding development programs.  With experience in over 365 Phase I – IV trials, Ergomed has planned, managed, monitored and reported clinical trials with a range of technologies that include small molecule drugs, monoclonal antibodies and other targeted agents as well as cancer vaccines, immunotherapy, radioactive agents and photodynamic therapies.


Industry specific information to provide guidance on the industries complex changes, updates and challenges.

CRO Resources